Skip to content
Search

Latest Stories

Surgical hubs, new technology to help tackle NHS waiting lists

Surgical hubs, new technology and innovative ways of working will help the NHS to tackle long waiting lists and treat around 30 per cent more elective care patients by 2023-24.

The recently announced funding of £36 billion for health and social care over the next three years and embracing innovation will be key drivers to get the NHS back on track.


The investment will enable the NHS deliver an extra 9 million checks, scans, and operations for patients across the country along with faster and more streamlined methods of treatments.

Surgical hubs that are being piloted in various locations, including London, are helping fast-track planned operations, such as cataract removal, hysterectomies and hip and knee replacements.

This service will be expanded across the country in the coming year.

Located on existing hospital sites, surgical hubs provide a mix of skills and resource under one roof while limiting infection risk in a Covid-19 secure environment.

Health secretary Sajid Javid said: “This global pandemic has presented enormous challenges for the NHS and led to a growing backlog – we cannot go on with business as usual.

“We are going to harness the latest technology and innovative new ways of working such as surgical hubs to deliver the millions more appointments, treatments and surgeries that are needed over the coming months and years to tackle waiting lists.”

A record 5.5 million people are currently waiting for non-urgent treatment and surgery, and around seven million patients in England have delayed their treatment during the pandemic.

The waiting list could potentially reach 13 million by the end of the year if left unchecked.

Professor Steve Powis, NHS England medical director, said: “...the NHS has already made effective use of additional resources to recover services –– from adopting the latest technologies to more evening and weekend working, NHS staff are going to great lengths to increase the number of operations carried out.”

The NHS has been trying a range of new ways of working, which includes setting up pop-up clinics to treat patients quickly, in person, and closer to home, as well as virtual wards, freeing up beds in hospitals.

Besides, GP surgeries are using Artificial Intelligence to help prioritise patients most in need and identify the right level of care and support needed for patients on waiting lists.

With an additional funding of £5.4 billion over the next 6 months for NHS, it will support its response to Covid-19. This includes an extra £1 billion to help tackle the Covid backlog.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less